We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
ImmunityBio
IBRX
$7.96B
| $774K | ﹤0.01% |
314,623
-19,934
| -6% | -$51.3K |
|
|
GLIBK
2327
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$954M
| $773K | ﹤0.01% |
+20,744
| New | +$732K |
|
|
NESR
2328
National Energy Services Reunited Corp
NESR
$3.41B
| $773K | ﹤0.01% |
75,321
-1,976
| -3% | -$15.8K |
|
2329
Aspen Aerogels
ASPN
$541M
| $771K | ﹤0.01% |
110,732
-2,774
| -2% | -$19.6K |
|
2330
NWPX Infrastructure Inc
NWPX
$1.15B
| $770K | ﹤0.01% |
14,547
+367
| +3% | +$17.5K |
|
2331
Honda
HMC
$41.1B
| $768K | ﹤0.01% |
24,947
-8,790
| -26% | -$287K |
|
2332
SmartFinancial
SMBK
$887M
| $767K | ﹤0.01% |
21,459
-713
| -3% | -$25.5K |
|
2333
Arhaus
ARHS
$1.38B
| $763K | ﹤0.01% |
71,807
-1,808
| -2% | -$19K |
|
|
GOLD
2334
Gold.com Inc
GOLD
$1.26B
| $757K | ﹤0.01% |
29,260
-1,706
| -6% | -$40.4K |
|
|
PHLT
2335
DELISTED
Performant Healthcare Inc
PHLT
| $757K | ﹤0.01% |
97,919
-6,464
| -6% | -$41.1K |
|
|
SERV
2336
Serve Robotics
SERV
$438M
| $757K | ﹤0.01% |
65,078
-1,946
| -3% | -$21.3K |
|
2337
ORIX
IX
$42.9B
| $757K | ﹤0.01% |
28,963
-14,232
| -33% | -$353K |
|
2338
Xerox
XRX
$423M
| $755K | ﹤0.01% |
200,750
-159,474
| -44% | -$705K |
|
2339
Consolidated Water Co
CWCO
$485M
| $752K | ﹤0.01% |
21,308
-780
| -4% | -$24.8K |
|
2340
Aquestive Therapeutics
AQST
$571M
| $752K | ﹤0.01% |
134,470
-6,402
| -5% | -$27.7K |
|
2341
Bumble
BMBL
$368M
| $752K | ﹤0.01% |
123,418
-4,164
| -3% | -$28.4K |
|
2342
Varex Imaging
VREX
$776M
| $751K | ﹤0.01% |
60,605
-1,215
| -2% | -$12K |
|
2343
Rush Enterprises Class B
RUSHB
$6.14B
| $749K | ﹤0.01% |
13,038
-735
| -5% | -$41.4K |
|
2344
Farmers National Banc Corp
FMNB
$928M
| $749K | ﹤0.01% |
51,960
-3,477
| -6% | -$49.8K |
|
2345
Rigel Pharmaceuticals
RIGL
$752M
| $748K | ﹤0.01% |
26,405
-660
| -2% | -$19.7K |
|
2346
Fulgent Genetics
FLGT
$528M
| $744K | ﹤0.01% |
32,927
-212
| -0.6% | -$4.37K |
|
2347
Third Coast Bancshares
TCBX
$735M
| $743K | ﹤0.01% |
19,568
-89
| -0.5% | -$3.38K |
|
2348
Invesco Mortgage Capital
IVR
$798M
| $743K | ﹤0.01% |
98,247
-6,677
| -6% | -$51K |
|
|
FPI
2349
Farmland Partners
FPI
$421M
| $742K | ﹤0.01% |
68,230
-5,626
| -8% | -$61.6K |
|
2350
Tronox
TROX
$1.02B
| $740K | ﹤0.01% |
184,203
+192
| +0.1% | +$879 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.